Frank Borriello MD, PhD

Frank Borriello is the founder and CEO of Alloplex Biotherapeutics, a private, clinical-stage Boston-based company launched in 2016 based on an original and now patented concept. He obtained his MD and PhD degrees at the Albert Einstein College of Medicine and continued training at the Brigham and Women’s Hospital in Boston with a residency in clinical pathology and a focus on cellular immunology. He has an extensive background in the biotech/pharma industry of over 20 years, which spans diverse roles in clinical development, biotech financial analysis, external innovation due diligence, and business development. Dr. Borriello has lived and worked in the Boston area since 1991.